Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Recruiting

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(8 sites)

United States

Yale University - Yale University School of Medicine, New Haven, Connecticut

Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville, North Carolina

NEXT Houston, Galveston, Texas

NEXT Oncology - PARENT, San Antonio, Texas

Canada

Princess Margaret Cancer Centre, Toronto